Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Theseus Pharmaceuticals, Inc. (THRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/19/2023 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 328,482 shares
@ $3.05, valued at
$1M
Bought 151,450 shares
@ $3.05, valued at
$461.9k
|
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 523,450 shares
@ $2.97, valued at
$1.6M
Bought 176,550 shares
@ $2.97, valued at
$524.4k
|
|
| 03/02/2023 |
4
| Rivera Victor (Chief Scientific Officer) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 16,250 restricted stock units
@ $0 |
|
| 03/02/2023 |
4
| Shakespeare William (See Remarks) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 21,250 restricted stock units
@ $0 |
|
| 03/02/2023 |
4
| Kerstein David (Chief Medical Officer) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 restricted stock units
@ $0 |
|
| 03/02/2023 |
4
| Dahms Bradford D. (CFO) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 restricted stock units
@ $0 |
|
| 03/02/2023 |
4
| CLACKSON TIMOTHY P (President and CEO) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 45,625 restricted stock units
@ $0 |
|
| 01/03/2023 |
4
| Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 250,000 shares
@ $5, valued at
$1.3M
Bought 250,000 shares
@ $5, valued at
$1.3M
|
|
| 01/03/2023 |
4
| HAYDEN DONALD J JR (Director) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 100 shares
@ $5, valued at
$500
Bought 9,900 shares
@ $4.9989, valued at
$49.5k
|
|
| 12/01/2022 |
4
| Dahms Bradford D. (CFO) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 1,502 shares
@ $6.657, valued at
$10k
|
|
| 11/09/2022 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 192,000 shares
@ $5.21, valued at
$1M
|
|
| 11/09/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 192,000 shares
@ $5.21, valued at
$1M
|
|
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Kerstein David (Chief Medical Officer) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $11.21, valued at
$1.7M
|
|
| 02/23/2022 |
4
| CLACKSON TIMOTHY P (President and CEO) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 450,000 options to buy
@ $11.21, valued at
$5M
|
|
| 02/23/2022 |
4
| Dalgarno David (Chief Technical Officer) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 130,000 options to buy
@ $11.21, valued at
$1.5M
|
|
| 02/23/2022 |
4
| Dahms Bradford D. (CFO) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $11.21, valued at
$1.7M
|
|
| 02/23/2022 |
4
| Shakespeare William (See Remarks) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 180,000 options to buy
@ $11.21, valued at
$2M
|
|
| 02/23/2022 |
4
| Rivera Victor (Chief Scientific Officer) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 130,000 options to buy
@ $11.21, valued at
$1.5M
|
|
| 01/21/2022 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 11,521 shares
@ $9.97, valued at
$114.9k
Bought 35,000 shares
@ $9.95, valued at
$348.3k
Bought 111,896 shares
@ $9.97, valued at
$1.1M
|
|
| 01/21/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 11,521 shares
@ $9.97, valued at
$114.9k
Bought 35,000 shares
@ $9.95, valued at
$348.3k
Bought 111,896 shares
@ $9.97, valued at
$1.1M
|
|
| 01/13/2022 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 1,600 shares
@ $9.81, valued at
$15.7k
Bought 6,900 shares
@ $10.67, valued at
$73.6k
Bought 18,897 shares
@ $10.06, valued at
$190.1k
Bought 17,320 shares
@ $9.43, valued at
$163.3k
|
|
| 01/13/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 1,600 shares
@ $9.81, valued at
$15.7k
Bought 6,900 shares
@ $10.67, valued at
$73.6k
Bought 18,897 shares
@ $10.06, valued at
$190.1k
Bought 17,320 shares
@ $9.43, valued at
$163.3k
|
|
| 12/22/2021 |
4
| CLACKSON TIMOTHY P (President and CEO) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 2,600 shares
@ $9.7621, valued at
$25.4k
|
|
| 12/22/2021 |
4
| Dahms Bradford D. (CFO) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 1,970 shares
@ $10.1521, valued at
$20k
|
|
| 10/15/2021 |
4
| TAKEDA PHARMACEUTICAL CO LTD (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Converted 1,615,427 shares
@ $0
Converted 1,615,427 preferred shares
@ $0 |
|
| 10/14/2021 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Converted 15,777,018 shares
@ $0
Converted 436,650 shares
@ $0
Bought 562,500 shares
@ $16, valued at
$9M
Bought 62,500 shares
@ $16, valued at
$1M
Converted 14,903,718 convertible preferred
@ $0
Converted 873,300 convertible preferred
@ $0
Converted 436,650 convertible preferred
@ $0 |
|
| 10/14/2021 |
4
| Shakespeare William (See Remarks) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 625 shares
@ $16, valued at
$10k
|
|
| 10/14/2021 |
4
| Rock Springs Capital Management LP (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Converted 349,320 shares
@ $0
Converted 87,329 shares
@ $0
Bought 250,000 shares
@ $16, valued at
$4M
Converted 349,320 convertible preferred
@ $0
Converted 87,329 convertible preferred
@ $0 |
|
|
|
|